These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bone metastases studied by experimental models. Galasko CS Schweiz Med Wochenschr; 1981 Dec; 111(49):1862-8. PubMed ID: 7330640 [No Abstract] [Full Text] [Related]
3. Timing of indomethacin in the control of prostaglandins, osteoclasts and bone destruction produced by VX2 carcinoma in rabbits. Galasko CS; Rawlins R; Bennett A Br J Cancer; 1979 Sep; 40(3):360-4. PubMed ID: 508564 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of lytic and blastic metastatic disease of bone. Galasko CS Clin Orthop Relat Res; 1982 Sep; (169):20-7. PubMed ID: 7105580 [TBL] [Abstract][Full Text] [Related]
5. The effect of prostaglandin synthesis inhibitors and diphosphonates on tumour-mediated osteolysis. Galasko CS; Samuel AW; Rushton S; Lacey E Br J Surg; 1980 Jul; 67(7):493-6. PubMed ID: 7417751 [TBL] [Abstract][Full Text] [Related]
6. In vitro osteolysis by human breast tumours. Easty GC; Dowsett M; Powles TJ; Easty DM; Gazet JC; Neville AM Proc R Soc Med; 1977 Mar; 70(3):191-5. PubMed ID: 193116 [No Abstract] [Full Text] [Related]
7. Hypercalcemia and tumor-prostaglandins: the VX2 carcinoma model in the rabbit. Voelkel EF; Tashjian AH; Franklin R; Wasserman E; Levine L Metabolism; 1975 Aug; 24(8):973-86. PubMed ID: 1143092 [TBL] [Abstract][Full Text] [Related]
8. Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins. Galasko CS; Bennett A Nature; 1976 Oct; 263(5577):508-10. PubMed ID: 972698 [No Abstract] [Full Text] [Related]
9. Patterns and mechanisms of bone metastases. Carter RL J R Soc Med; 1985; 78 Suppl 9(Suppl 9):2-6. PubMed ID: 4045915 [No Abstract] [Full Text] [Related]
10. Prostaglandins and hypercalcemic states. Seyberth HW; Raisz LG; Oates JA Annu Rev Med; 1978; 29():23-9. PubMed ID: 348034 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms for the development of bone metastases and hypercalcaemia in patients with breast cancer. Powles TJ Proc R Soc Med; 1977 Mar; 70(3):199-201. PubMed ID: 323867 [No Abstract] [Full Text] [Related]
13. [Diphosphonates in the treatment of bone metastases]. Jung A; Fleisch H Schweiz Med Wochenschr; 1981 Dec; 111(49):1878-82. PubMed ID: 6460313 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of bone remodeling induced by tumors: tumor humors. Tashjian AH Schweiz Med Wochenschr; 1981 Dec; 111(49):1869-72. PubMed ID: 6800026 [No Abstract] [Full Text] [Related]
15. Prostaglandins and cancer. Smith BJ; Wills MR; Savory J Ann Clin Lab Sci; 1983; 13(5):359-65. PubMed ID: 6357045 [TBL] [Abstract][Full Text] [Related]
16. Bone metastasis: can osteoclasts be excluded? Martin TJ; Mundy GR Nature; 2007 Feb; 445(7130):E19; discussion E19-20. PubMed ID: 17314931 [TBL] [Abstract][Full Text] [Related]
17. Effects of prostaglandin on experimental bone malignancy and on scintigrams of bone and marrow. Otsuka N; Ito Y; Nagai K; Terashima H; Yanagimoto S; Muranaka A J Nucl Med; 1981 May; 22(5):433-40. PubMed ID: 6452515 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of bone destruction in the development of skeletal metastases. Galasko CS Nature; 1976 Oct; 263(5577):507-8. PubMed ID: 972697 [No Abstract] [Full Text] [Related]
19. Effects of VX-2 carcinoma implanted in bone in rabbits. Enneking WF; Flynn L Cancer Res; 1968 Jun; 28(6):1007-13. PubMed ID: 5658436 [No Abstract] [Full Text] [Related]
20. Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis. Lynch CC Bone; 2011 Jan; 48(1):44-53. PubMed ID: 20601294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]